{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-008863","form_type":"8-K","ticker":"MRK","cik":"0000310158","company_name":"Merck & Co., Inc.","filed_at":"2025-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.928808+00:00","generated_at":"2026-05-27T03:42:09.434020+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Merck Q4 2024 sales $15.6B (+7% YoY); GAAP EPS $1.48, Non-GAAP $1.72; FY2025 guidance issued","bullets":["Full-year 2024 worldwide sales $64.2B (+7% YoY; +10% ex-FX).","Q4 GAAP EPS $1.48; Non-GAAP EPS $1.72 (includes $0.23 charge for licensing).","KEYTRUDA full-year sales $29.5B (+18% YoY; +22% ex-FX).","WINREVAIR full-year sales $419M; GARDASIL declined 3% to $8.6B on lower China demand.","FY2025 guidance: sales $64.1-65.6B; Non-GAAP EPS $8.88-9.03 (incl. ~$0.09 LaNova charge)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-008863","json":"https://secwatch.observer/filing/0001104659-25-008863.json","markdown":"https://secwatch.observer/filing/0001104659-25-008863.md","text":"https://secwatch.observer/filing/0001104659-25-008863.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310158/000110465925008863/0001104659-25-008863-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310158/000110465925008863/tm255059d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T03:42:09.434020+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}